» Authors » Gorkem Kismali

Gorkem Kismali

Explore the profile of Gorkem Kismali including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 293
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kismali G, Manyam G, Jain N, Ivan C, Lamothe B, Ayres M, et al.
Blood Cancer J . 2024 Dec; 14(1):220. PMID: 39695112
Historically, CLL prognostication relied on disease burden, reflected in clinical stage. Later, chromosome abnormalities and genomics suggested several CLL subtypes which were aligned with response to therapy. Gene expression profiling...
2.
Meral O, Emen F, Kutlu E, Demirdogen R, Kinayturk N, Kismali G, et al.
Turk J Chem . 2023 Sep; 47(1):280-293. PMID: 37720851
Bis(4-(4-nitrobenzyl)pyridine)dichloropalladium(II), [PdClL], bis(2-amino-5-bromopyridine)dichloropalladium(II), [PdClL], bis(2,4-dimethylpyridine)dichloropalladium(II), [PdClL], bis(3,4-dimethylpyridine)dichloropalladium(II), [PdClL] were prepared. The spectroscopic techniques (FT-IR and H-NMR, C-NMR) were used to characterize the compounds. Theoretical calculations were used to validate the...
3.
Demirbas Y, Kismali G, Saral B, Sareyyupoglu B, Habiloglu A, Ozturk H, et al.
J Vet Behav . 2023 Jan; 60:79-88. PMID: 36628157
Medical detection dogs have potential to be used to screen asymptomatic patients in crowded areas at risk of epidemics such as the SARS-CoV-2 pandemic. However, the fact that SARS-CoV-2 detection...
4.
Ozgur-Buyukatalay E, Demirbas Y, Bozdayi G, Kismali G, Ilhan M
Appl Anim Behav Sci . 2023 Jan; 258:105825. PMID: 36589678
Medical detection dogs have a high potential for use as alternative diagnostic tools not only for organic diseases, but also for infectious diseases. However, new variants emerging over time may...
5.
Gokcen S, Kurt B, Kucukbagriacik Y, Ozgur-Buyukatalay E, Kismali G
Electromagn Biol Med . 2022 Jul; 41(3):325-334. PMID: 35786241
In this study, it is aimed to investigate the effect of radiofrequency radiation (RFR) on apoptotic and antiapoptotic factors under different exposure conditions in human colonic adenocarcinoma cells (Caco-2). We...
6.
Aslan B, Kismali G, Iles L, Manyam G, Ayres M, Chen L, et al.
Blood Cancer J . 2022 May; 12(5):80. PMID: 35595730
Pirtobrutinib (LOXO-305), a reversible inhibitor of Bruton's tyrosine kinase (BTK), was designed as an alternative strategy to treat ibrutinib-resistant disease that develops due to C481 kinase domain mutations. The clinical...
7.
Aslan B, Kismali G, Chen L, Iles L, Mahendra M, Peoples M, et al.
Blood Adv . 2021 Aug; 5(16):3134-3146. PMID: 34424317
Although ibrutinib improves the overall survival of patients with chronic lymphocytic leukemia (CLL), some patients still develop resistance, most commonly through point mutations affecting cysteine residue 481 (C481) in Bruton's...
8.
Sayiner S, Fidanci U, Kucukersan S, Kismali G, Meral O, Ozer Sehirli A, et al.
Trop Anim Health Prod . 2020 Jan; 52(4):1869-1874. PMID: 31953691
Vitamin A, calcium (Ca), phosphorus (P) and magnesium (Mg) are essential components for the health and reproductive yield of dairy cows. In this study, it is aimed to profile the...
9.
Yi X, Sarkar A, Kismali G, Aslan B, Ayres M, Iles L, et al.
Clin Cancer Res . 2020 Jan; 26(14):3856-3867. PMID: 31937611
Purpose: Survival of CLL cells due to the presence of Bcl-2 and Mcl-1 has been established. Direct inhibition of Bcl-2 by venetoclax and indirect targeting of Mcl-1 with transcription inhibitors...
10.